Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
letter
. 1993 Nov;69(817):893–894. doi: 10.1136/pgmj.69.817.893-a

Aspirin and risk of fatal colon cancer.

G P Morgan, J G Williams
PMCID: PMC2399913  PMID: 8290442

Full text

PDF
893

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Attallah A., Lee J. B., Ambrus J. L., Ambrus C. M., Karakousis C., Takita H. Prostaglandin E2 production by human tumors. Defense mechanism against the host? A preliminary report. Res Commun Chem Pathol Pharmacol. 1984 Feb;43(2):195–201. [PubMed] [Google Scholar]
  2. Balch C. M., Dougherty P. A., Cloud G. A., Tilden A. B. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients. Surgery. 1984 Jan;95(1):71–77. [PubMed] [Google Scholar]
  3. Bennett A., Tacca M. D., Stamford I. F., Zebro T. Prostaglandins from tumours of human large bowel. Br J Cancer. 1977 Jun;35(6):881–884. doi: 10.1038/bjc.1977.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Koyama H., Narisawa T., Kodama M., Ishikawa K., Kusaka H., Yamazaki Y., Koyama K. [Potent effects of the prostaglandin synthesis inhibitor indomethacin on the cellular immune response in gastrointestinal cancer patients]. Nihon Gan Chiryo Gakkai Shi. 1989 May 20;24(5):1027–1033. [PubMed] [Google Scholar]
  5. Metzger U., Meier J., Uhlschmid G., Weihe H. Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer. Dis Colon Rectum. 1984 Jun;27(6):366–369. doi: 10.1007/BF02553001. [DOI] [PubMed] [Google Scholar]
  6. Moorghen M., Ince P., Finney K. J., Sunter J. P., Watson A. J., Appleton D. R. The effect of sulindac on colonic tumour formation in dimethylhydrazine-treated mice. Acta Histochem Suppl. 1990;39:195–199. [PubMed] [Google Scholar]
  7. Narisawa T., Kusaka H., Yamazaki Y., Takahashi M., Koyama H., Koyama K., Fukaura Y., Wakizaka A. Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer. Dis Colon Rectum. 1990 Oct;33(10):840–845. doi: 10.1007/BF02051919. [DOI] [PubMed] [Google Scholar]
  8. Odeh M. Aspirin and risk of fatal colon cancer. Postgrad Med J. 1993 Mar;69(809):242–242. doi: 10.1136/pgmj.69.809.242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Pollard M., Luckert P. H. Treatment of chemically-induced intestinal cancers with indomethacin. Proc Soc Exp Biol Med. 1981 Jun;167(2):161–164. doi: 10.3181/00379727-167-41142. [DOI] [PubMed] [Google Scholar]
  10. Reddy B. S., Nayini J., Tokumo K., Rigotty J., Zang E., Kelloff G. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res. 1990 May 1;50(9):2562–2568. [PubMed] [Google Scholar]
  11. Waddell W. R., Ganser G. F., Cerise E. J., Loughry R. W. Sulindac for polyposis of the colon. Am J Surg. 1989 Jan;157(1):175–179. doi: 10.1016/0002-9610(89)90442-x. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES